Your browser doesn't support javascript.
loading
Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination.
Chhabra, Saurabh; Szabo, Aniko; Clurman, Annelie; McShane, Katelynn; Waters, Nicholas; Eastwood, Daniel; Samanas, Lisa; Fei, Teng; Armijo, Gabriel; Abedin, Sameen; Longo, Walter; Hari, Parameswaran; Hamadani, Mehdi; Shah, Nirav N; Runaas, Lyndsey; Jerkins, James H; Van den Brink, Marcel; Peled, Jonathan U; Drobyski, William R.
Affiliation
  • Chhabra S; From the Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin. schhabra@mcw.edu.
  • Szabo A; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin.
  • Clurman A; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center.
  • McShane K; Cancer Center Clinical Trials Office, Medical College of Wisconsin.
  • Waters N; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center.
  • Eastwood D; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin.
  • Samanas L; Department of Pharmacy, Froedtert Health.
  • Fei T; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center.
  • Armijo G; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center.
  • Abedin S; From the Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin.
  • Longo W; From the Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin.
  • Hari P; From the Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin.
  • Hamadani M; From the Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin.
  • Shah NN; From the Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin.
  • Runaas L; From the Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin.
  • Jerkins JH; From the Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin.
  • Van den Brink M; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.
  • Peled JU; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.
  • Drobyski WR; From the Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin. wdrobysk@mcw.edu.
Haematologica ; 108(1): 250-256, 2023 01 01.
Article in En | MEDLINE | ID: mdl-36106394
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Limits: Humans Language: En Journal: Haematologica Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Limits: Humans Language: En Journal: Haematologica Year: 2023 Document type: Article